Neuraptive Therapeutics, Inc.
Neuraptive is developing surgical products to address the nerve repair market.
- Stage Product In Development
- Industry Biotechnology
- Location Louisville, CO, USA
- Currency USD
- Founded November 2016
- Employees 7
- Incorporation Type C-corp
- Website neuraptive.com
Company Summary
Neuraptive is a clinical-stage company developing products to address the >$5B surgical nerve repair market. The Company's flagship product, the AxoFuse Nerve Repair Kit is a simple-to-use surgical kit that delivers already approved pharmaceutical agents to achieve rapid and dramatically improved recovery of nerve function in acutely injured patients. This will be the first truly therapeutic product to address this major unmet medical need.
Team
-
CEO20+ yrs in development and commercialization of regulated healthcare technologies; (2) successful exits as management; experienced with FDA, EMA; trained in intellectual property; formerly licensed as Analyst with SEC/FINRA.
-
CDO20+ years experience with pharmaceutical product manufacture and development, from synthesis to finished drug product and use thereof in multiple clinical development programs; experienced with FDA, EMA.
-
VP Clinical Operations25+ years in clinical operations in drug/device trials, including various acute care indications from Phase 1 to Phase 3 trials. Several years at senior level positions in biotech startups. Extensive experience in the management of multi-center trials in US and EU.
-
VP OperationsDr Costantini is an experienced healthcare product entrepreneur and executive with 25+ years in neuroscience R&D, product development and commercialization. She has raised capital, achieved regulatory approval and taken products to market.
Advisors
Previous Investors
-
Dr Melissa KounineUnconfirmed -
Lone Star Paralysis FoundationUnconfirmed
New Rhein Healthcare Investors LLCUnconfirmed
Central Texas Angel NetworkUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.